
Clinical trials
Studies registered on ClinicalTrials.gov, anchored to the NCT number.
Search the catalog
Filters1
Filters
Closeness to humans
Closeness to humans:Early human trials
Order:Newest
2 cards found
Card descriptions are written in Russian for now; English text is coming.
NCT04867616. Bepranemab (UCB0107) in prodromal to mild Alzheimer's disease
Phase 2NCT04867616
Completed phase 2 trial sponsored by UCB Biopharma SRL. Primary completion 24 May 2024. The Lancet Neurology report (PMID 43008775) says the CDR-SB primary endpoint was not met.
1 news item
PURIFY-TIMI 81 (YN001)
Phase 2NCT07521007
Phase 2b, N≈456, randomized double-blind placebo-controlled; primary endpoint relative change coronary noncalcified plaque volume.
1 news item